Top AI-powered pharma companies that have successfully secured AI in drug development

Applications of artificial intelligence are inevitably employed almost in every industry, and we all are nearly aware of them. AI marketing techniques are flooding in the digital space and its direction towards the target audience. Artificial intelligence is usually heaved for its characteristic of emulating human behavior that occurs through analysis and underlying observation. Therefore, pharmaceutical companies are employing this ability of AI in the drug development process to yield high-end results without laying out unnecessary time, money, and human labor instead of it. Eventually, some of the AI-powered pharma companies are worth talking about as they grow significantly in their endeavor. 

Pfizer

The pharmaceuticals company has reported collaborating with some of the renowned tech entities in the world like IBM Watson, Massachusetts Institute of Technology, XTalPi for causes like immuno-oncology, drug discovery, and molecular stability. Besides, Pfizer is also said to have built a platform equipped with artificial intelligence that can detect rare diseases in patients. Some of the prominent partnerships of the AI-powered pharma company also include CytoReason, Concerto HealthAI, Catalia Health.

Roche

The AI-powered pharma company has dedicated its artificial intelligence to diagnosing macular oedema, which means the retina thickness occurs in diabetic patients. Machine learning algorithms are built to predict the occurrence, progression, and treatment of the patient. Further involving ophthalmologists in the procedure through the electronic medium for personalized care. Moreover, the pharmaceutical company also extracts oncology-based data from Flatiron Health, which was acquired by them for further advancement in its artificial intelligence.

Novartis

The pharmaceuticals company has a long record of tying up with various tech institutions like IBM Watson, MIT, McKinsey’s Quantum Black e.t.c. But of all the collaborations, two are noteworthy that is Partnership with Intel on tapping deep-neural networks to accelerate the early steps of drug developments and the other alliance with Microsoft, which is potentially dedicated to transforming the conventional process of drug development and commercialization.

Johnson And Johnson

Besides, collaborations with popular AI and Ml operators of the world for the cause of drug development and finding suitable drug candidates. The AI-powered pharma company has its application over the digital space namely Skin 360, which helps in providing intense observation of the skin reflecting its need, state, and progress. Another attempt with artificial intelligence has been quite successful of JandJ, that, vision assistant Andy, which is a chatbot that helps people procuring contact lens treatment and advice.

MSD

Under the affiliation of the Velocity Health program, Merck and Wayra are aiming at the prevention of diabetes and cancer. Alongside, the pharmaceutical company uses artificial intelligence to cut down various chronic diseases that are recognized by FDA. The collaboration of MSD, Accenture, and AWS focuses on making drug development more accurate and efficient besides, increasing productivity with the machine learning applications and large sets of real-world data.

Sanofi

The pharmaceutical company possessing expertise in drug development concerning genome sciences have strong ties with Researchable which helps it use AI for sifting studies and findings from a large set of data that are relevant to the stakeholders. Moreover, the collaboration with Google signifies the creation of a virtual Innovation Lab that brings them insights from patient records.

Abbvie

The AI-powered pharma company is in the growth stages of drug development and discovering therapies. However, reports suggest it has a list of confidential initiatives lined up. It also has a partnership with AiCure for the phase 2 schizophrenia trial implemented by them.

GlaxoSmithKline

The pharmaceutical company is more or less known to all of us and serves as a household name as a lot of medicines from the company are consumed by a large population. The AI-powered pharma company has an in-house unit of artificial intelligence that is dedicated to drug development. The collaboration with Google helps the pharmaceutical company to build biomedical medicines catering to modify irregular impulses and the application is implantable. 

Amgen

Having been a determined investor in GNS healthcare, it has narrowed its focus to precision medicine. Nevertheless, MIT’s Pharmaceutical discovery and synthesis consortium also include the participation of Amgen.

Gilead Sciences

Since April 2019, Gilead Sciences is a well-known AI-powered pharma company. Their collaboration with Insitro will shape the nonalcoholic steatohepatitis treatment model and diagnose its progress.